| Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis A Moeller, SE Gilpin, K Ask, G Cox, D Cook, J Gauldie, PJ Margetts, ... American journal of respiratory and critical care medicine 179 (7), 588-594, 2009 | 619 | 2009 |
| The monocrotaline model of pulmonary hypertension in perspective JG Gomez-Arroyo, L Farkas, AA Alhussaini, D Farkas, D Kraskauskas, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 302 (4 …, 2012 | 526 | 2012 |
| VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats L Farkas, D Farkas, K Ask, A Möller, J Gauldie, P Margetts, M Inman, ... The Journal of clinical investigation 119 (5), 1298-1311, 2009 | 262 | 2009 |
| Blocking Macrophage Leukotriene B4 Prevents Endothelial Injury and Reverses Pulmonary Hypertension W Tian, X Jiang, R Tamosiuniene, YK Sung, J Qian, G Dhillon, L Gera, ... Science translational medicine 5 (200), 200ra117-200ra117, 2013 | 253 | 2013 |
| Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors L Farkas, J Gauldie, NF Voelkel, M Kolb American journal of respiratory cell and molecular biology 45 (1), 1-15, 2011 | 252 | 2011 |
| Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension J Gomez-Arroyo, S Mizuno, K Szczepanek, B Van Tassell, R Natarajan, ... Circulation: Heart Failure 6 (1), 136-144, 2013 | 192 | 2013 |
| Differences in LPS‐induced activation of bronchial epithelial cells (BEAS‐2B) and type II‐like pneumocytes (A‐549) C Schulz, L Farkas, K Wolf, K Krätzel, G Eissner, M Pfeifer Scandinavian journal of immunology 56 (3), 294-302, 2002 | 179 | 2002 |
| New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis MR Nicolls, S Mizuno, L Taraseviciene-Stewart, L Farkas, JI Drake, ... Pulmonary circulation 2 (4), 434-442, 2012 | 143 | 2012 |
| Angiogenesis in pulmonary fibrosis: too much or not enough? C Hanumegowda, L Farkas, M Kolb Chest 142 (1), 200-207, 2012 | 133 | 2012 |
| Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization S Mizuno, L Farkas, A Al Husseini, D Farkas, J Gomez-Arroyo, ... American journal of respiratory cell and molecular biology 47 (5), 679-687, 2012 | 97 | 2012 |
| Oxidative stress contributes to the induction and persistence of TGF-â1 induced pulmonary fibrosis Y Cui, J Robertson, S Maharaj, L Waldhauser, J Niu, J Wang, L Farkas, ... The international journal of biochemistry & cell biology 43 (8), 1122-1133, 2011 | 91 | 2011 |
| IL-32 promotes angiogenesis CA Nold-Petry, I Rudloff, Y Baumer, M Ruvo, D Marasco, P Botti, L Farkas, ... The Journal of Immunology 192 (2), 589-602, 2014 | 85 | 2014 |
| Nuclear factor êB inhibition reduces lung vascular lumen obliteration in severe pulmonary hypertension in rats D Farkas, AA Alhussaini, D Kraskauskas, V Kraskauskiene, CD Cool, ... American journal of respiratory cell and molecular biology 51 (3), 413-425, 2014 | 79 | 2014 |
| Transient overexpression of Gremlin results in epithelial activation and reversible fibrosis in rat lungs L Farkas, D Farkas, J Gauldie, D Warburton, W Shi, M Kolb American journal of respiratory cell and molecular biology 44 (6), 870-878, 2011 | 79 | 2011 |
| Comparison between conventional and" clinical" assessment of experimental lung fibrosis K Ask, R Labiris, L Farkas, A Moeller, A Froese, T Farncombe, ... Journal of Translational Medicine 6, 1-10, 2008 | 78 | 2008 |
| Iloprost reverses established fibrosis in experimental right ventricular failure J Gomez-Arroyo, M Sakagami, AA Syed, L Farkas, B Van Tassell, ... European Respiratory Journal 45 (2), 449-462, 2015 | 77 | 2015 |
| Toll-like receptor 3 is a therapeutic target for pulmonary hypertension D Farkas, AAR Thompson, AR Bhagwani, S Hultman, H Ji, N Kotha, ... American Journal of Respiratory and Critical Care Medicine 199 (2), 199-210, 2019 | 61 | 2019 |
| In Vivo Role of Platelet-Derived Growth Factor–BB in Airway Smooth Muscle Proliferation in Mouse Lung JA Hirota, K Ask, L Farkas, JA Smith, R Ellis, JC Rodriguez-Lecompte, ... American journal of respiratory cell and molecular biology 45 (3), 566-572, 2011 | 59 | 2011 |
| CXCR4 Inhibition Ameliorates Severe Obliterative Pulmonary Hypertension and Accumulation of C-Kit+ Cells in Rats D Farkas, D Kraskauskas, JI Drake, AA Alhussaini, V Kraskauskiene, ... PloS one 9 (2), e89810, 2014 | 55 | 2014 |
| Copper dependence of angioproliferation in pulmonary arterial hypertension in rats and humans HJ Bogaard, S Mizuno, C Guignabert, AA Al Hussaini, D Farkas, G Ruiter, ... American journal of respiratory cell and molecular biology 46 (5), 582-591, 2012 | 55 | 2012 |
Martin KolbProfessor of Medicine, McMaster University HamiltonVerified email at mcmaster.ca
